◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow high confidence — graded ✗ wrong
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
5sources
5articles
3velocity
+0%since first seen
14d agofirst detected
Text:
🤖 AI Dossier
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Who reported it (5)
-
-
-
-
-
Novo Nordisk’s ziltivekimab stumbles again on pair of Phase III terminations Clinical Trials Arena · 14d ago broke it first
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Related trends
🔥 Breakout ↑ Rising
Business
Shopify to Use Meta’s Muse for Agentic Checkout
↑ Rising
Business
GameStop CEO Ryan Cohen Buys Another $26 Million of GME Stock
▲ Peaking
Business
Satellite industry grapples with the end of Falcon 9
↑ Rising
Business
Sept. 19 Powerball results: 31 players come heartbreakingly close to winning the $298M jackpot
↓ Cooling
Business
🔮 holds
Wall Street Is Growing Skeptical of the Data Center Boom
↑ Rising
Business
🔮 holds